Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2005
10/02/2005CA2461375A1 Cea binding agents compositions to reverse cea-mediated tumorigenic effects on human cancer cells, restore sensitivity to drug induced apoptosis and uses thereof
09/2005
09/29/2005WO2005090971A1 Anti-lipid rafts antibodies
09/29/2005WO2005090579A1 Modified bouganin proteins, cytotoxins and methods and uses thereof
09/29/2005WO2005090573A2 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
09/29/2005WO2005090569A1 Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof
09/29/2005WO2005090407A1 Human anti-epidermal growth factor receptor antibody
09/29/2005WO2005090406A2 Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth
09/29/2005WO2005090405A1 Subtype of humanized antibody against interleukin-6 receptor
09/29/2005WO2005090404A2 Compositions and methods for detecting cyclic analogs of human parathyroid hormone (hpth)
09/29/2005WO2005090403A2 Method and apparatus for antibody purification
09/29/2005WO2005090399A1 Antibody recognizing the proliferation/differentiation of various types of cells and method of evaluating proliferation/differentiation by using the antibody
09/29/2005WO2005090393A2 Multimeric protein toxins to target cells having multiple identifying characteristics
09/29/2005WO2005090391A1 Novel tat complexes, and vaccines comprising them
09/29/2005WO2005090381A1 Set1 proteins and uses therefor
09/29/2005WO2005089813A2 Receptor-avid exogenous optical contrast and therapeutic agents
09/29/2005WO2005089809A2 Calicheamicin conjugation by antibody deglycosylation
09/29/2005WO2005089808A2 Antibody calicheamicin conjugates
09/29/2005WO2005089807A2 Antibody calicheamicin conjugates for passive targeting
09/29/2005WO2005089802A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
09/29/2005WO2005089799A1 Cytotoxicity method using effector function of anti-fam3d antibody
09/29/2005WO2005089798A1 Monovalent ligand of the fcalphari receptor as an anti-inflammatory agent
09/29/2005WO2005089503A2 Cd4-igg2 formulations
09/29/2005WO2005089372A2 Therapeutic synergy of anti-cancer compounds
09/29/2005WO2005089285A2 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
09/29/2005WO2005089093A2 Improved expression systems with sec-system secretion
09/29/2005WO2005079508A3 Method and composition for angiogenesis inhibition
09/29/2005WO2005067620A3 ANTIBODIES TO MAdCAM
09/29/2005WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof
09/29/2005WO2005063335A3 MONOCLONAL DES-LYS58-β2-MICROGLOBULIN ANTIBODIES FOR MEASUREMENT AND MANAGEMENT OF HEMODIALYSIS COMPLICATIONS
09/29/2005WO2005056807A3 Bovine adeno-associated viral (baav) vector and uses thereof
09/29/2005WO2005052169A3 Plant disease resistance and sar regulator protein
09/29/2005WO2005038005A9 Shc proteins as therapeutic targets in proliferative diseases
09/29/2005WO2005029066A3 Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof
09/29/2005WO2005025509A3 Methods and materials for treating autoimmune diseases and conditions
09/29/2005WO2005023205A3 Compositions and methods for yersinia pestis treatment
09/29/2005WO2005007674A3 Anti-human vitronectin antibody and methods for making the same
09/29/2005WO2005003171A3 Modified antibody fragments
09/29/2005WO2004099410A3 Compound and method for regulating plasminogen activation and cell migration
09/29/2005WO2004063355A3 Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer
09/29/2005WO2004058820A3 Single-domain-effector group and its uses
09/29/2005WO2004050682A3 Phosphospecific pak antibodies and diagnostic kits
09/29/2005WO2004043239A3 Antigen pipa and antibodies that bind thereto
09/29/2005WO2003076469A9 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
09/29/2005US20050216958 Fucosyltransferase knock-out host cell for use as bioreactors in production of preferentially modified glycoproteins
09/29/2005US20050215770 Antibodies against Nogo receptor
09/29/2005US20050215769 Protein purification
09/29/2005US20050215768 Polypeptides including modified constant regions
09/29/2005US20050215767 Fcgamma riib specific antibodies and methods of use thereof
09/29/2005US20050215766 Allergen from mugwort pollen
09/29/2005US20050214942 Activation and expansion of cells
09/29/2005US20050214910 Chordin-like molecules and uses thereof
09/29/2005US20050214907 Immunoglobulins and method for their modification
09/29/2005US20050214873 Monoclonal antibody for use in classification and identification of embryonic connective tissue progenitor cells; regenerative medicine
09/29/2005US20050214872 Antibodies isolating and/or identifying neuronal stem cells and method for isolating and/or identifying neuronal progenitor cells
09/29/2005US20050214871 Using CD163 (Cluster of Differentiation 163) protein as tool in identifying modulator for prevention and treatment of cardiovascular, autoimmune, nervous system and inflammatory disorders
09/29/2005US20050214861 Human hematopoietic stem and progenitor antigen and methods for its use
09/29/2005US20050214860 Immunoglobulin specific to endothelial growth factor receptor (KDR) for use as tool in treating cell proliferative disorders; antitumor agents; angiogenesis inhibitors
09/29/2005US20050214857 Method for displaying loops from immunoglobulin domains in different contexts
09/29/2005US20050214856 Nucleotide sequences coding bone morphogenic protein for identifying modulators for treatment of bone diseases
09/29/2005US20050214848 Reagents and methods useful for detecting diseases of the breast
09/29/2005US20050214846 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/29/2005US20050214845 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
09/29/2005US20050214844 Nucleotide sequences coding translocation protein for use in identifying modulators for prevention and treatment of cell proliferative ,inflammatory and autoimmune disorders
09/29/2005US20050214837 Antibody specific for mutant presenilin 1 and method of use thereof
09/29/2005US20050214828 Using ultrviolet laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics
09/29/2005US20050214819 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/29/2005US20050214795 Polypeptide for use as diagnostic indicator of cell proliferative disorders; immunotherapeutics; antitumor agents
09/29/2005US20050214794 Alstroem syndrome gene, gene variants, expressed protein and methods of diagnosis for alstroem syndrome
09/29/2005US20050214790 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of schizophrenia
09/29/2005US20050214756 Cell visual characteristic-modifying sequences
09/29/2005US20050214314 Human cytokine receptor
09/29/2005US20050214309 Methods and compositions for modulating transcription factor activity
09/29/2005US20050214308 by administering a STIgMA polypeptide or its agonist; autoimmune, respiratory, kidney, skin, cardiovascular disorders, hepatitis
09/29/2005US20050214307 Antibody conjugates for treatment of neoplastic disease
09/29/2005US20050214304 Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
09/29/2005US20050214303 Methods for damaging cells using effector functions of anti FAM3D antibodies
09/29/2005US20050214302 Use of emmprin antagonists for the treatment of diseases associated with excessive angiogenesis
09/29/2005US20050214301 Antibodies specific for BCR-ABL fusion protein and uses thereof
09/29/2005US20050214300 Methods for treating cancer using Porimin as a target
09/29/2005US20050214299 Method of inhibiting stenosis and restenosis
09/29/2005US20050214298 Neovascular-targeted immunoconjugates
09/29/2005US20050214297 Methods and compositions relating to chitinases and chitinase-like molecules and modulation of osteoclasts
09/29/2005US20050214296 Methods of modulating cytokine activity; related reagents
09/29/2005US20050214295 Combined chemotherapy compositions and methods for the treatment of cancer, ischemia-reperfusion injury, and septic shock
09/29/2005US20050214294 Diabetic nephropathy therapies
09/29/2005US20050214293 Containing heavy and light chain complementarity determining region 1,2 and 3 components of amino acid sequences 1-6; reduced immunogenicity; increased affinity and avidity; improved cell culturing
09/29/2005US20050214291 Treatment method
09/29/2005US20050214290 Methods of blocking tissue destruction by autoreactive T cells
09/29/2005US20050214289 Antibodies against Nogo receptor
09/29/2005US20050214288 Antibodies against Nogo receptor
09/29/2005US20050214287 Methods and compositions for modulating angiogenesis
09/29/2005US20050214286 Polymer-bound antibody cancer therapeutic agent
09/29/2005US20050214285 Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE, antagonists thereof, and their therapeutic uses
09/29/2005US20050214283 Antibodies to CD44 glycoforms and uses thereof
09/29/2005US20050214282 Expressed genes that define the osteoclast phenotype
09/29/2005US20050214281 G-protein coupled receptor
09/29/2005US20050214280 Utilizing antibody, antisense agent, RNA interference component and/or triplex nucleic acid forming molecule as vascular endothelial growth factor B antagonist
09/29/2005US20050214278 Antibody-containing solution pharmaceuticals
09/29/2005US20050214265 Tolerance conditioning and multiday delayed transplantation; depleting alpha beta - and gamma delta -TCR+ T cells and/or CD8+ T cells
09/29/2005US20050214252 Chordin-like molecules and uses thereof
1 ... 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 ... 1494